ALTEOGEN Statistics
Total Valuation
ALTEOGEN has a market cap or net worth of KRW 11.90 trillion. The enterprise value is 11.57 trillion.
Important Dates
The next estimated earnings date is Friday, November 20, 2026.
| Earnings Date | Nov 20, 2026 |
| Ex-Dividend Date | Dec 29, 2025 |
Share Statistics
ALTEOGEN has 69.62 million shares outstanding. The number of shares has increased by 0.76% in one year.
| Current Share Class | 69.62M |
| Shares Outstanding | 69.62M |
| Shares Change (YoY) | +0.76% |
| Shares Change (QoQ) | -1.75% |
| Owned by Insiders (%) | 25.26% |
| Owned by Institutions (%) | 12.35% |
| Float | 52.04M |
Valuation Ratios
The trailing PE ratio is 65.47 and the forward PE ratio is 33.80.
| PE Ratio | 65.47 |
| Forward PE | 33.80 |
| PS Ratio | 46.71 |
| PB Ratio | 22.11 |
| P/TBV Ratio | 22.25 |
| P/FCF Ratio | 194.96 |
| P/OCF Ratio | 121.44 |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 88.90, with an EV/FCF ratio of 189.52.
| EV / Earnings | 60.16 |
| EV / Sales | 45.40 |
| EV / EBITDA | 88.90 |
| EV / EBIT | 96.30 |
| EV / FCF | 189.52 |
Financial Position
The company has a current ratio of 5.73, with a Debt / Equity ratio of 0.01.
| Current Ratio | 5.73 |
| Quick Ratio | 5.10 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.05 |
| Debt / FCF | 0.12 |
| Interest Coverage | 8.80 |
Financial Efficiency
Return on equity (ROE) is 35.60% and return on invested capital (ROIC) is 59.05%.
| Return on Equity (ROE) | 35.60% |
| Return on Assets (ROA) | 11.15% |
| Return on Invested Capital (ROIC) | 59.05% |
| Return on Capital Employed (ROCE) | 18.46% |
| Weighted Average Cost of Capital (WACC) | 10.08% |
| Revenue Per Employee | 1.40B |
| Profits Per Employee | 1.06B |
| Employee Count | 181 |
| Asset Turnover | 0.38 |
| Inventory Turnover | 11.18 |
Taxes
In the past 12 months, ALTEOGEN has paid 18.27 billion in taxes.
| Income Tax | 18.27B |
| Effective Tax Rate | 8.46% |
Stock Price Statistics
The stock price has decreased by -59.46% in the last 52 weeks. The beta is 1.04, so ALTEOGEN's price volatility has been similar to the market average.
| Beta (5Y) | 1.04 |
| 52-Week Price Change | -59.46% |
| 50-Day Moving Average | 231,628.00 |
| 200-Day Moving Average | 267,395.46 |
| Relative Strength Index (RSI) | 30.27 |
| Average Volume (20 Days) | 474,421 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ALTEOGEN had revenue of KRW 254.01 billion and earned 191.70 billion in profits. Earnings per share was 2,610.42.
| Revenue | 254.01B |
| Gross Profit | 205.43B |
| Operating Income | 119.79B |
| Pretax Income | 216.06B |
| Net Income | 191.70B |
| EBITDA | 129.75B |
| EBIT | 119.79B |
| Earnings Per Share (EPS) | 2,610.42 |
Full Income Statement Balance Sheet
The company has 446.84 billion in cash and 7.01 billion in debt, with a net cash position of 439.83 billion or 6,317.18 per share.
| Cash & Cash Equivalents | 446.84B |
| Total Debt | 7.01B |
| Net Cash | 439.83B |
| Net Cash Per Share | 6,317.18 |
| Equity (Book Value) | 644.98B |
| Book Value Per Share | 7,704.47 |
| Working Capital | 430.76B |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was 97.69 billion and capital expenditures -36.84 billion, giving a free cash flow of 60.85 billion.
| Operating Cash Flow | 97.69B |
| Capital Expenditures | -36.84B |
| Depreciation & Amortization | 9.96B |
| Net Borrowing | -536.39M |
| Free Cash Flow | 60.85B |
| FCF Per Share | 874.02 |
Full Cash Flow Statement Margins
Gross margin is 80.88%, with operating and profit margins of 47.16% and 75.47%.
| Gross Margin | 80.88% |
| Operating Margin | 47.16% |
| Pretax Margin | 85.06% |
| Profit Margin | 75.47% |
| EBITDA Margin | 51.08% |
| EBIT Margin | 47.16% |
| FCF Margin | 23.96% |
Dividends & Yields
This stock pays an annual dividend of 285.38, which amounts to a dividend yield of 0.17%.
| Dividend Per Share | 285.38 |
| Dividend Yield | 0.17% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 10.43% |
| FCF Payout Ratio | 32.65% |
| Buyback Yield | -0.76% |
| Shareholder Yield | -0.59% |
| Earnings Yield | 1.53% |
| FCF Yield | 0.51% |
Dividend Details Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside | |
Analyst Forecast
The average price target for ALTEOGEN is 358,333.33, which is 109.67% higher than the current price. The consensus rating is "Buy".
| Price Target | 358,333.33 |
| Price Target Difference | 109.67% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | 60.04% |
| EPS Growth Forecast (3Y) | 56.30% |
Stock Splits
The last stock split was on August 5, 2026. It was a forward split with a ratio of 1.3.
| Last Split Date | Aug 5, 2026 |
| Split Type | Forward |
| Split Ratio | 1.3 |
Scores
ALTEOGEN has an Altman Z-Score of 145.64 and a Piotroski F-Score of 7.
| Altman Z-Score | 145.64 |
| Piotroski F-Score | 7 |